Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal DebtTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Skyward Specialty Insurance (SKWD) Cash & Equivalents (2021 - 2026)

Skyward Specialty Insurance has reported Cash & Equivalents over the past 6 years, most recently at $255.9 million for Q1 2026.

  • Quarterly Cash & Equivalents rose 126.64% to $255.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $255.9 million through Mar 2026, up 126.64% year-over-year, with the annual reading at $168.5 million for FY2025, 38.6% up from the prior year.
  • Cash & Equivalents was $255.9 million for Q1 2026 at Skyward Specialty Insurance, up from $168.5 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $255.9 million in Q1 2026 and troughed at $41.2 million in Q1 2023.
  • The 5-year median for Cash & Equivalents is $95.3 million (2024), against an average of $106.6 million.
  • Year-over-year, Cash & Equivalents grew 7.91% in 2022 and then soared 126.64% in 2026.
  • A 5-year view of Cash & Equivalents shows it stood at $45.4 million in 2022, then surged by 45.01% to $65.9 million in 2023, then soared by 84.55% to $121.6 million in 2024, then surged by 38.6% to $168.5 million in 2025, then soared by 51.84% to $255.9 million in 2026.
  • Per Business Quant, the three most recent readings for SKWD's Cash & Equivalents are $255.9 million (Q1 2026), $168.5 million (Q4 2025), and $160.1 million (Q3 2025).